PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge, UK bpc28@cam.ac.uk.\', \'The Center for Research and Interdisciplinarity, Paris, France.\', \'Department of Computer Science and Systems Engineering, University of Zaragoza, Zaragoza, Spain.\', \'Department of Biochemistry, University of Cambridge, Cambridge, UK.\', \'EMBL-EBI, European Bioinformatics Institute, Hinxton, UK.\', \'Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge, UK arf27@cam.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • e20200095410.26508/lsa.202000954
?:hasPublicationType
?:journal
  • Life science alliance
is ?:pmid of
?:pmid
?:pmid
  • 34353886
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Integrated human/SARS-CoV-2 metabolic models present novel treatment strategies against COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34353886>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34353886>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all